Norm,
many thanks for your comments on HC. It is unsusual to see these honest opinion in a public board. I recall very well ur "sell" sentiment at 2,2x. It was the perfect signal from a very experienced guy, at least for me.
Agree on the projects. NB is in the same state as 2.5 years ago, were M/C was at 20 mio A$. 3 years later we may see an update of the resource, well... it should be better significant.
My main concern today is that I don't understand how a chemical company is working. I dont't like BASF and the like, don't understand how they make money. I do like mines. Aru looks like they want to become a chemical company.
For me they are a startup, not technology, but chemical. Not an explorer. Developer? They try but results ... what results they achieved in 2.5 years since 20 mio A$ m/c? I only recall they figured out that they need 750 mio A$ +- 30% to bring the mine online, pay back period very much in excess of 3 years. Given the current situation with costs in the industry I read it as +30%.
Pisa_
- Forums
- ASX - By Stock
- ARU
- insane selling
insane selling, page-19
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ARU (ASX) to my watchlist
(20min delay)
|
|||||
Last
13.0¢ |
Change
-0.005(3.70%) |
Mkt cap ! $338.8M |
Open | High | Low | Value | Volume |
13.5¢ | 14.0¢ | 13.0¢ | $354.6K | 2.621M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
71 | 2652982 | 13.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
13.5¢ | 649312 | 29 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
71 | 2656411 | 0.130 |
38 | 2079599 | 0.125 |
50 | 2175037 | 0.120 |
19 | 831659 | 0.115 |
20 | 1159923 | 0.110 |
Price($) | Vol. | No. |
---|---|---|
0.135 | 649312 | 29 |
0.140 | 1906274 | 22 |
0.145 | 1096765 | 19 |
0.150 | 3098261 | 13 |
0.155 | 533716 | 11 |
Last trade - 13.42pm 13/11/2024 (20 minute delay) ? |
Featured News
ARU (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online